Percutaneous coronary intervention provided better long term results than optimal medical therapy alone in patients

Dibbendhu Khanra1, Vikas Mishra2, Bhavna Jain3

  • 1New Cross Hospital, Royal Wolverhampton NHS Trust, UK.

Indian Heart Journal
|August 31, 2020
PubMed

Insights

Percutaneous coronary intervention (PCI) plus optimal medical therapy (OMT) significantly reduces major adverse cardiovascular events and mortality in chronic total occlusion (CTO) patients compared to OMT alone. Long-term outcomes favor PCI, with similar revascularization rates.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Chronic total occlusion (CTO) management often involves percutaneous coronary intervention (PCI) alongside optimal medical therapy (OMT), but comparative long-term outcome data are limited.
  • Existing studies on PCI+OMT versus OMT alone for CTO have design limitations, including observational data, variable follow-up, and high patient drop-out or cross-over rates.

Purpose of the Study:

  • To conduct a comprehensive meta-analysis of both observational and randomized studies.
  • To compare the long-term clinical outcomes of PCI plus OMT versus OMT alone in patients with CTO.

Main Methods:

  • Systematic review of PubMed, Embase, and Cochrane databases.
  • Inclusion of 15 studies, with quality appraisal using the Newcastle Ottawa scale.
  • Random-effects model with inverse variance method to analyze data on major adverse cardiovascular events (MACE), mortality, and revascularization.

Main Results:

  • PCI+OMT significantly reduced MACE (cardiac death, myocardial infarction, stroke, unplanned revascularization) compared to OMT alone (RR: 0.76; 95% CI: 0.61-0.95).
  • All-cause mortality and cardiac death were significantly lower in the PCI+OMT group (P<0.00001 for both).
  • While myocardial infarction and stroke rates were lower with PCI+OMT, they did not reach statistical significance. Unplanned revascularization rates were similar between groups.

Conclusions:

  • Percutaneous coronary intervention for CTO, when combined with optimal medical therapy, leads to improved long-term outcomes.
  • Key benefits include a reduction in major adverse cardiovascular events, all-cause mortality, and cardiac death.
  • The rates of unplanned revascularization remain comparable between the PCI+OMT and OMT alone strategies.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
134
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
155
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
157
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
160
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
120
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
232